1
|
Dos Santos Nascimento IJ, Albino SL, da Silva Menezes KJ, de Azevedo Teotônio Cavalcanti M, de Oliveira MS, Mali SN, de Moura RO. Targeting SmCB1: Perspectives and Insights to Design Antischistosomal Drugs. Curr Med Chem 2024; 31:2264-2284. [PMID: 37921174 DOI: 10.2174/0109298673255826231011114249] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/31/2023] [Revised: 09/01/2023] [Accepted: 09/14/2023] [Indexed: 11/04/2023]
Abstract
Neglected tropical diseases (NTDs) are prevalent in tropical and subtropical countries, and schistosomiasis is among the most relevant diseases worldwide. In addition, one of the two biggest problems in developing drugs against this disease is related to drug resistance, which promotes the demand to develop new drug candidates for this purpose. Thus, one of the drug targets most explored, Schistosoma mansoni Cathepsin B1 (SmCB1 or Sm31), provides new opportunities in drug development due to its essential functions for the parasite's survival. In this way, here, the latest developments in drug design studies targeting SmCB1 were approached, focusing on the most promising analogs of nitrile, vinyl sulphones, and peptidomimetics. Thus, it was shown that despite being a disease known since ancient times, it remains prevalent throughout the world, with high mortality rates. The therapeutic arsenal of antischistosomal drugs (ASD) consists only of praziquantel, which is widely used for this purpose and has several advantages, such as efficacy and safety. However, it has limitations, such as the impossibility of acting on the immature worm and exploring new targets to overcome these limitations. SmCB1 shows its potential as a cysteine protease with a catalytic triad consisting of Cys100, His270, and Asn290. Thus, design studies of new inhibitors focus on their catalytic mechanism for designing new analogs. In fact, nitrile and sulfonamide analogs show the most significant potential in drug development, showing that these chemical groups can be better exploited in drug discovery against schistosomiasis. We hope this manuscript guides the authors in searching for promising new antischistosomal drugs.
Collapse
Affiliation(s)
- Igor José Dos Santos Nascimento
- Pharmacy Department, Cesmac University Center, Maceió, 57051-160, Brazil
- Laboratório de Desenvolvimento e Síntese de Fármacos, Departamento de Farmácia, Universidade Estadual da Paraíba, Campina Grande 58429-500, Brazil
- Programa de Pós Graduação em Ciências Farmacêuticas, Universidade Estadual da Paraíba, Campina Grande, 58429-500, Brazil
| | - Sonaly Lima Albino
- Laboratório de Desenvolvimento e Síntese de Fármacos, Departamento de Farmácia, Universidade Estadual da Paraíba, Campina Grande 58429-500, Brazil
| | - Karla Joane da Silva Menezes
- Laboratório de Desenvolvimento e Síntese de Fármacos, Departamento de Farmácia, Universidade Estadual da Paraíba, Campina Grande 58429-500, Brazil
- Programa de Pós Graduação em Ciências Farmacêuticas, Universidade Estadual da Paraíba, Campina Grande, 58429-500, Brazil
| | - Misael de Azevedo Teotônio Cavalcanti
- Laboratório de Desenvolvimento e Síntese de Fármacos, Departamento de Farmácia, Universidade Estadual da Paraíba, Campina Grande 58429-500, Brazil
- Programa de Pós Graduação em Ciências Farmacêuticas, Universidade Estadual da Paraíba, Campina Grande, 58429-500, Brazil
| | - Mozaniel Santana de Oliveira
- Coordination of Botany-Laboratory Adolpho Ducke, Avenida Perimetral, Museu Paraense Emílio Goeldi, 1901, Belém, 66077-530, PA Brazil
| | - Suraj N Mali
- Department of Pharmaceutical Sciences and Technology, Institute of Chemical Technology, Matunga East, Mumbai, 400019, India
| | - Ricardo Olimpio de Moura
- Laboratório de Desenvolvimento e Síntese de Fármacos, Departamento de Farmácia, Universidade Estadual da Paraíba, Campina Grande 58429-500, Brazil
- Programa de Pós Graduação em Ciências Farmacêuticas, Universidade Estadual da Paraíba, Campina Grande, 58429-500, Brazil
| |
Collapse
|
2
|
Xu J, Dong LL, Sun H, Huang P, Zhang RZ, Wang XY, Sun DQ, Xia CM. Small change, big difference: A promising praziquantel derivative designated P96 with broad-spectrum antischistosomal activity for chemotherapy of schistosomiasis japonica. PLoS Negl Trop Dis 2023; 17:e0011215. [PMID: 37410790 DOI: 10.1371/journal.pntd.0011215] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/03/2023] [Accepted: 06/21/2023] [Indexed: 07/08/2023] Open
Abstract
BACKGROUND Praziquantel (PZQ) has been the first line antischistosomal drug for all species of Schistosoma, and the only available drug for schistosomiasis japonica, without any alternative drugs since the 1980s. However, PZQ cannot prevent reinfection, and cannot cure schistosomiasis thoroughly because of its poor activity against juvenile schistosomes. In addition, reliance on a single drug is extremely dangerous, the development and spread of resistance to PZQ is becoming a great concern. Therefore, development of novel drug candidates for treatment and control of schistosomiasis is urgently needed. METHODOLOGYS/PRINCIPAL FINDINGS One of the PZQ derivative christened P96 with the substitution of cyclohexyl by cyclopentyl was synthesized by School of Pharmaceutical Sciences of Shandong University. We investigated the in vitro and in vivo activities of P96 against different developmental stages of S. japonicum. Parasitological studies and scanning electron microscopy were used to study the primary action characteristics of P96 in vitro. Both mouse and rabbit models were employed to evaluate schistosomicidal efficacy of P96 in vivo. Besides calculation of worm reduction rate and egg reduction rate, quantitative real-time PCR was used to evaluate the in vivo antischistosomal activity of P96 at molecular level. In vitro, after 24h exposure, P96 demonstrated the highest activities against both juvenile and adult worm of S. japonicum in comparison to PZQ. The antischistosomal efficacy was concentration-dependent, with P96 at 50μM demonstrating the most evident schistosomicidal effect. Scanning electron microscopy demonstrated that P96 caused more severe damages to schistosomula and adult worm tegument compared to PZQ. In vivo, our results showed that P96 was effective against S. japonicum at all developmental stages. Notably, its efficacy against young stage worms was significantly improved compared to PZQ. Moreover, P96 retained the high activity comparable to PZQ against the adult worm of S. japonicum. CONCLUSIONS P96 is a promising drug candidate for chemotherapy of schistosomiasis japonica, which has broad spectrum of action against various developmental stage, potentially addressing the deficiency of PZQ. It might be promoted as a drug candidate for use either alone or in combination with PZQ for the treatment of schistosomiasis.
Collapse
Affiliation(s)
- Jing Xu
- Department of Parasitology, School of Biology & Basic Medical Sciences, Suzhou Medical College of Soochow University, Suzhou City, Jiangsu Province, P. R. China
- MOE Key Laboratory of Geriatric Diseases and Immunology, Suzhou Key Laboratory of Pathogen Bioscience and Anti-infective Medicine, School of Biology & Basic Medical Sciences, Suzhou Medical College, Soochow University, Jiangsu Province, P.R. China
| | - Lan-Lan Dong
- Department of Parasitology, School of Biology & Basic Medical Sciences, Suzhou Medical College of Soochow University, Suzhou City, Jiangsu Province, P. R. China
| | - Huan Sun
- Department of Parasitology, School of Biology & Basic Medical Sciences, Suzhou Medical College of Soochow University, Suzhou City, Jiangsu Province, P. R. China
| | - Ping Huang
- Department of Parasitology, School of Biology & Basic Medical Sciences, Suzhou Medical College of Soochow University, Suzhou City, Jiangsu Province, P. R. China
- MOE Key Laboratory of Geriatric Diseases and Immunology, Suzhou Key Laboratory of Pathogen Bioscience and Anti-infective Medicine, School of Biology & Basic Medical Sciences, Suzhou Medical College, Soochow University, Jiangsu Province, P.R. China
| | - Run-Ze Zhang
- Department of Parasitology, School of Biology & Basic Medical Sciences, Suzhou Medical College of Soochow University, Suzhou City, Jiangsu Province, P. R. China
| | - Xin-Yi Wang
- Department of Parasitology, School of Biology & Basic Medical Sciences, Suzhou Medical College of Soochow University, Suzhou City, Jiangsu Province, P. R. China
| | - De-Qun Sun
- School of Life Science and Engineering, Southwest University of Science and Technology, Qingyi Town, Mianyang City, Sichuan Province, P. R. China
| | - Chao-Ming Xia
- Department of Parasitology, School of Biology & Basic Medical Sciences, Suzhou Medical College of Soochow University, Suzhou City, Jiangsu Province, P. R. China
- MOE Key Laboratory of Geriatric Diseases and Immunology, Suzhou Key Laboratory of Pathogen Bioscience and Anti-infective Medicine, School of Biology & Basic Medical Sciences, Suzhou Medical College, Soochow University, Jiangsu Province, P.R. China
| |
Collapse
|
3
|
Grishina NY, Sazonova EV, Artemov AN. Azole and Azine Derivatives Containing (η6-Arene)tricarbonylchromium Substituents. RUSSIAN JOURNAL OF ORGANIC CHEMISTRY 2022. [DOI: 10.1134/s107042802206001x] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 11/22/2022]
|
4
|
|
5
|
Lin Y, Ong YC, Keller S, Karges J, Bouchene R, Manoury E, Blacque O, Müller J, Anghel N, Hemphill A, Häberli C, Taki AC, Gasser RB, Cariou K, Keiser J, Gasser G. Synthesis, characterization and antiparasitic activity of organometallic derivatives of the anthelmintic drug albendazole. Dalton Trans 2021; 49:6616-6626. [PMID: 32347259 DOI: 10.1039/d0dt01107j] [Citation(s) in RCA: 6] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/21/2022]
Abstract
Helminthiases, a group of neglected tropical diseases, affect more than one billion people mainly in tropical and subtropical regions. Moreover, major intestinal protozoa have a significant impact on global public health. Albendazole (ABZ) is a broad-spectrum anthelmintic recommended by the World Health Organisation (WHO). However, drug resistance is emerging due to its widespread use. In order to tackle this problem, taking into account the spectacular results obtained with ferroquine, an organometallic derivatization of the antimalarial drug chloroquine, we have prepared, in this study, a series of new ferrocenyl and ruthenocenyl derivatives of the organic drug ABZ and assessed their activity against different helminths and protozoans, namely Trichuris muris, Heligmosomoides polygygrus, Schistosoma mansoni, Giardia lamblia, Haemonchus contortus and Toxoplasma gondii. The ferrocene-containing ABZ analogue 2d exhibited over 70% activity against T. muris adults in vitro at 200 μM and no toxicity to mammalian cells (IC50 >100 μM). H. polygyrus adults were not affected by any of the derivatives tested. Against T. gondii, the ferrocene-containing ABZ analogues 1a and 2d showed better in vitro activity than ABZ and low toxicity to the host cells. The activity of the analogous ruthenocenyl compound 2b against S. mansoni and T. gondii in vitro might be attributed to its toxicity towards the host cells rather than a specific antiparasitic activity. These results demonstrate that the derivatives show a species specific in vitro activity and the choice of the organometallic moieties attached to the organic drug is playing a very important role. Two of our organometallic compounds, namely 1b and 2d, were tested in T. muris infected mice. At a 400 mg kg-1 dose, the compounds showed moderate worm burden reductions but low worm expulsion rates. Overall, this work, which is one of the first studies reporting the potential of organometallic compounds on a very broad range of parasitic helminths and protozoan, is a clear confirmation of the potential of organometallic complexes against parasites of medical and veterinary importance.
Collapse
Affiliation(s)
- Yan Lin
- Chimie ParisTech, PSL University, CNRS, Institute of Chemistry for Life and Health Sciences, Laboratory for Inorganic Chemical Biology, 75005 Paris, France.
| | - Yih Ching Ong
- Chimie ParisTech, PSL University, CNRS, Institute of Chemistry for Life and Health Sciences, Laboratory for Inorganic Chemical Biology, 75005 Paris, France.
| | - Sarah Keller
- Chimie ParisTech, PSL University, CNRS, Institute of Chemistry for Life and Health Sciences, Laboratory for Inorganic Chemical Biology, 75005 Paris, France.
| | - Johannes Karges
- Chimie ParisTech, PSL University, CNRS, Institute of Chemistry for Life and Health Sciences, Laboratory for Inorganic Chemical Biology, 75005 Paris, France.
| | - Rafika Bouchene
- CNRS, LCC (Laboratoire de Chimie de Coordination), Université de Toulouse, UPS, INPT, 205 Route de Narbonne, BP 44099, 31077 Toulouse, France and Département Sciences de la Matière, Faculté des Sciences Exactes, Université Larbi Ben M'hidi, BP 358, Route de Constantine, 04000 Oum El Bouaghi, Algeria
| | - Eric Manoury
- CNRS, LCC (Laboratoire de Chimie de Coordination), Université de Toulouse, UPS, INPT, 205 Route de Narbonne, BP 44099, 31077 Toulouse, France
| | - Olivier Blacque
- Department of Chemistry, University of Zurich, Winterthurerstrasse 190, 8057 Zurich, Switzerland
| | - Joachim Müller
- Institute of Parasitology, University of Bern, Länggass-Strasse 122, 3012 Bern, Switzerland
| | - Nicoleta Anghel
- Institute of Parasitology, University of Bern, Länggass-Strasse 122, 3012 Bern, Switzerland
| | - Andrew Hemphill
- Institute of Parasitology, University of Bern, Länggass-Strasse 122, 3012 Bern, Switzerland
| | - Cécile Häberli
- Department of Medical Parasitology and Infection Biology, Swiss Tropical and Public Health Institute, Socinstr. 57, Basel, Switzerland. and University of Basel, Basel, Switzerland
| | - Aya C Taki
- Department of Veterinary Biosciences, Melbourne Veterinary School, Faculty of Veterinary and Agricultural Sciences, The University of Melbourne, Parkville, Victoria 3010, Australia
| | - Robin B Gasser
- Department of Veterinary Biosciences, Melbourne Veterinary School, Faculty of Veterinary and Agricultural Sciences, The University of Melbourne, Parkville, Victoria 3010, Australia
| | - Kevin Cariou
- Chimie ParisTech, PSL University, CNRS, Institute of Chemistry for Life and Health Sciences, Laboratory for Inorganic Chemical Biology, 75005 Paris, France.
| | - Jennifer Keiser
- Department of Medical Parasitology and Infection Biology, Swiss Tropical and Public Health Institute, Socinstr. 57, Basel, Switzerland. and University of Basel, Basel, Switzerland
| | - Gilles Gasser
- Chimie ParisTech, PSL University, CNRS, Institute of Chemistry for Life and Health Sciences, Laboratory for Inorganic Chemical Biology, 75005 Paris, France.
| |
Collapse
|
6
|
Chellan P, Sadler PJ. Enhancing the Activity of Drugs by Conjugation to Organometallic Fragments. Chemistry 2020; 26:8676-8688. [PMID: 32452579 PMCID: PMC7496994 DOI: 10.1002/chem.201904699] [Citation(s) in RCA: 62] [Impact Index Per Article: 15.5] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/15/2019] [Revised: 02/12/2020] [Indexed: 12/22/2022]
Abstract
Resistance to chemotherapy is a current clinical problem, especially in the treatment of microbial infections and cancer. One strategy to overcome this is to make new derivatives of existing drugs by conjugation to organometallic fragments, either by an appropriate linker, or by direct coordination of the drug to a metal. We illustrate this with examples of conjugated organometallic metallocene sandwich and half-sandwich complexes, RuII and OsII arene, and RhIII and IrIII cyclopentadienyl half-sandwich complexes. Ferrocene conjugates are particularly promising. The ferrocene-chloroquine conjugate ferroquine is in clinical trials for malaria treatment, and a ferrocene-tamoxifen derivative (a ferrocifen) seems likely to enter anticancer trails soon. Several other examples illustrate that organometallic conjugation can restore the activity of drugs to which resistance has developed.
Collapse
Affiliation(s)
- Prinessa Chellan
- Department of Chemistry and Polymer ScienceStellenbosch University7600Matieland, Western CapeSouth Africa
| | - Peter J. Sadler
- Department of ChemistryUniversity of WarwickCoventryCV4 7ALUK
| |
Collapse
|
7
|
Dziwornu GA, Attram HD, Gachuhi S, Chibale K. Chemotherapy for human schistosomiasis: how far have we come? What's new? Where do we go from here? RSC Med Chem 2020; 11:455-490. [PMID: 33479649 PMCID: PMC7593896 DOI: 10.1039/d0md00062k] [Citation(s) in RCA: 9] [Impact Index Per Article: 2.3] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/24/2020] [Accepted: 03/22/2020] [Indexed: 01/11/2023] Open
Abstract
Globally, schistosomiasis threatens more than 700 million lives, mostly children, in poor localities of tropical and sub-tropical areas with morbidity due to acute and chronic pathological manifestations of the disease. After a century since the first antimonial-based drugs were introduced to treat the disease, anti-schistosomiasis drug development is again at a bottleneck with only one drug, praziquantel, available for treatment purposes. This review focuses on promising chemotypes as potential starting points in a drug discovery effort to meet the urgent need for new schistosomicides.
Collapse
Affiliation(s)
- Godwin Akpeko Dziwornu
- Department of Chemistry , University of Cape Town , Rondebosch 7701 , South Africa . ; Tel: +27 21 6502553
| | - Henrietta Dede Attram
- Department of Chemistry , University of Cape Town , Rondebosch 7701 , South Africa . ; Tel: +27 21 6502553
| | - Samuel Gachuhi
- Department of Chemistry , University of Cape Town , Rondebosch 7701 , South Africa . ; Tel: +27 21 6502553
| | - Kelly Chibale
- Department of Chemistry , University of Cape Town , Rondebosch 7701 , South Africa . ; Tel: +27 21 6502553
- Drug Discovery and Development Centre (H3D) , University of Cape Town , Rondebosch 7701 , South Africa
- Institute of Infectious Disease and Molecular Medicine , University of Cape Town , Rondebosch 7701 , South Africa
- South African Medical Research Council Drug Discovery and Development Research Unit , University of Cape Town , Rondebosch 7701 , South Africa
| |
Collapse
|
8
|
Ong YC, Roy S, Andrews PC, Gasser G. Metal Compounds against Neglected Tropical Diseases. Chem Rev 2018; 119:730-796. [DOI: 10.1021/acs.chemrev.8b00338] [Citation(s) in RCA: 90] [Impact Index Per Article: 15.0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/01/2023]
Affiliation(s)
- Yih Ching Ong
- Laboratory for Inorganic Chemical Biology, Chimie ParisTech, PSL University, 11 rue Pierre et Marie Curie, F-75005 Paris, France
| | - Saonli Roy
- Department of Chemistry, University of Zurich, Wintherthurerstrasse 190, CH-8057 Zurich, Switzerland
| | - Philip C. Andrews
- School of Chemistry, Monash University, Wellington Road, Clayton, Victoria 3800, Australia
| | - Gilles Gasser
- Laboratory for Inorganic Chemical Biology, Chimie ParisTech, PSL University, 11 rue Pierre et Marie Curie, F-75005 Paris, France
| |
Collapse
|
9
|
Basu U, Otto S, Heinze K, Gasser G. Biological Evaluation of the NIR-Emissive Ruby Analogue [Cr(ddpd)2
][BF4
]3
as a Photodynamic Therapy Photosensitizer. Eur J Inorg Chem 2018. [DOI: 10.1002/ejic.201801023] [Citation(s) in RCA: 22] [Impact Index Per Article: 3.7] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/26/2022]
Affiliation(s)
- Uttara Basu
- Laboratory for Inorganic Chemical Biology; Chimie ParisTech PSL University; 75005 Paris France
| | - Sven Otto
- Institute of Inorganic Chemistry and Analytical Chemistry; Johannes Gutenberg University of Mainz; Duesberweg 10-14 55128 Mainz Germany
- Graduate School Materials Science in Mainz; Staudingerweg 9 55128 Mainz Germany
| | - Katja Heinze
- Institute of Inorganic Chemistry and Analytical Chemistry; Johannes Gutenberg University of Mainz; Duesberweg 10-14 55128 Mainz Germany
| | - Gilles Gasser
- Laboratory for Inorganic Chemical Biology; Chimie ParisTech PSL University; 75005 Paris France
| |
Collapse
|
10
|
d'Orchymont F, Hess J, Panic G, Jakubaszek M, Gemperle L, Keiser J, Gasser G. Synthesis, characterization and biological activity of organometallic derivatives of the antimalarial drug mefloquine as new antischistosomal drug candidates. MEDCHEMCOMM 2018; 9:1905-1909. [PMID: 30568758 PMCID: PMC6256353 DOI: 10.1039/c8md00396c] [Citation(s) in RCA: 10] [Impact Index Per Article: 1.7] [Reference Citation Analysis] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 08/13/2018] [Accepted: 10/04/2018] [Indexed: 12/22/2022]
Abstract
We present the design, synthesis, characterization and biological evaluation of new ferrocenyl and ruthenocenyl derivatives of the organic antimalarial mefloquine, a drug also known for its antischistosomal activity. The two metallocenyl derivatives prepared (3 and 4) demonstrated comparable activity to mefloquine against adult-stage Schistosoma mansoni in vitro. Importantly, both compounds were found to have lower toxicity in all cell lines than mefloquine itself. Administration of a 200 mg kg-1 oral dose of 3 and 4 to S. mansoni-infected mice did not significantly reduce worm burden, contrary to mefloquine.
Collapse
Affiliation(s)
- Faustine d'Orchymont
- Department of Chemistry , University of Zurich , Winterthurerstrasse 190 , CH-8057 Zurich , Switzerland
| | - Jeannine Hess
- Department of Chemistry , University of Zurich , Winterthurerstrasse 190 , CH-8057 Zurich , Switzerland
| | - Gordana Panic
- Department of Medical Parasitology and Infection Biology , Swiss Tropical and Public Health Institute , CH-4051 , Basel , Switzerland .
- University of Basel , P.O. Box , CH-4003 Basel , Switzerland
| | - Marta Jakubaszek
- Laboratory for Inorganic Chemical Biology , Chimie ParisTech , PSL University , F-75005 Paris , France .
| | - Lea Gemperle
- Department of Chemistry , University of Zurich , Winterthurerstrasse 190 , CH-8057 Zurich , Switzerland
| | - Jennifer Keiser
- Department of Medical Parasitology and Infection Biology , Swiss Tropical and Public Health Institute , CH-4051 , Basel , Switzerland .
- University of Basel , P.O. Box , CH-4003 Basel , Switzerland
| | - Gilles Gasser
- Laboratory for Inorganic Chemical Biology , Chimie ParisTech , PSL University , F-75005 Paris , France .
| |
Collapse
|
11
|
Hess J, Panic G, Patra M, Mastrobuoni L, Spingler B, Roy S, Keiser J, Gasser G. Ferrocenyl, Ruthenocenyl, and Benzyl Oxamniquine Derivatives with Cross-Species Activity against Schistosoma mansoni and Schistosoma haematobium. ACS Infect Dis 2017; 3:645-652. [PMID: 28686009 DOI: 10.1021/acsinfecdis.7b00054] [Citation(s) in RCA: 23] [Impact Index Per Article: 3.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/30/2022]
Abstract
Schistosomiasis is a parasitic disease that affects more than 250 million people annually, mostly children in poor, tropical, rural areas. Only one treatment (praziquantel) is available, putting control efforts at risk should resistance occur. In pursuit of treatment alternatives, we derivatized an old antischistosomal agent, oxamniquine (OXA). Four organometallic derivatives of OXA were synthesized and tested against Schistosoma mansoni in vitro and in vivo. Of these, a ferrocenyl derivative, 1, killed larval and adult worms 24 h postexposure in vitro, in contrast to OXA, which lacks in vitro activity against adult worms. A dose of 200 mg/kg of 1 completely eliminated the worm burden in mice. Subsequently, a ruthenocenyl (5) and a benzyl derivative (6) of OXA were synthesized to probe the importance of the ferrocenyl group in 1. Compounds 1, 5, and 6 were lethal to both S. mansoni and S. haematobium adults in vitro. In vivo, at 100 mg/kg, all three compounds revealed S. mansoni worm burden reductions of 76 to 93%, commensurate with OXA. Our findings present three compounds with activity against S. mansoni in vitro, comparable activity in vivo, and high activity against S. haematobium in vitro. These compounds may possess a different binding mode or mode of action compared to OXA and present excellent starting points for further SAR studies.
Collapse
Affiliation(s)
- Jeannine Hess
- Department of Chemistry, University of Zurich, Winterthurerstrasse 190, CH-8057 Zurich, Switzerland
| | - Gordana Panic
- Department
of Medical Parasitology and Infection Biology, Swiss Tropical and Public Health Institute, Basel, Switzerland
- University of Basel, P.O. Box, CH-4003 Basel, Switzerland
| | - Malay Patra
- Department of Chemistry, University of Zurich, Winterthurerstrasse 190, CH-8057 Zurich, Switzerland
| | - Luciano Mastrobuoni
- Department of Chemistry, University of Zurich, Winterthurerstrasse 190, CH-8057 Zurich, Switzerland
| | - Bernhard Spingler
- Department of Chemistry, University of Zurich, Winterthurerstrasse 190, CH-8057 Zurich, Switzerland
| | - Saonli Roy
- Department of Chemistry, University of Zurich, Winterthurerstrasse 190, CH-8057 Zurich, Switzerland
| | - Jennifer Keiser
- Department
of Medical Parasitology and Infection Biology, Swiss Tropical and Public Health Institute, Basel, Switzerland
- University of Basel, P.O. Box, CH-4003 Basel, Switzerland
| | - Gilles Gasser
- Chimie ParisTech, PSL Research University, Laboratory for Inorganic Chemical Biology, F-75005 Paris, France
| |
Collapse
|
12
|
Characterization of the Activities of Dinuclear Thiolato-Bridged Arene Ruthenium Complexes against Toxoplasma gondii. Antimicrob Agents Chemother 2017; 61:AAC.01031-17. [PMID: 28652238 DOI: 10.1128/aac.01031-17] [Citation(s) in RCA: 30] [Impact Index Per Article: 4.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/17/2017] [Accepted: 06/22/2017] [Indexed: 12/13/2022] Open
Abstract
The in vitro effects of 18 dinuclear thiolato-bridged arene ruthenium complexes (1 monohiolato compound, 4 dithiolato compounds, and 13 trithiolato compounds), originally designed as anticancer agents, on the apicomplexan parasite Toxoplasma gondii grown in human foreskin fibroblast (HFF) host cells were studied. Some trithiolato compounds exhibited antiparasitic efficacy at concentrations of 250 nM and below. Among those, complex 1 and complex 2 inhibited T. gondii proliferation with 50% inhibitory concentrations (IC50s) of 34 and 62 nM, respectively, and they did not affect HFFs at dosages of 200 μM or above, resulting in selectivity indices of >23,000. The IC50s of complex 9 were 1.2 nM for T. gondii and above 5 μM for HFFs. Transmission electron microscopy detected ultrastructural alterations in the matrix of the parasite mitochondria at the early stages of treatment, followed by a more pronounced destruction of tachyzoites. However, none of the three compounds applied at 250 nM for 15 days was parasiticidal. By affinity chromatography using complex 9 coupled to epoxy-activated Sepharose followed by mass spectrometry, T. gondii translation elongation factor 1α and two ribosomal proteins, RPS18 and RPL27, were identified to be potential binding proteins. In conclusion, organometallic ruthenium complexes exhibit promising activities against Toxoplasma, and the potential mechanisms of action of these compounds as well as their prospective applications for the treatment of toxoplasmosis are discussed.
Collapse
|
13
|
Hess J, Huang H, Kaiser A, Pierroz V, Blacque O, Chao H, Gasser G. Evaluation of the Medicinal Potential of Two Ruthenium(II) Polypyridine Complexes as One- and Two-Photon Photodynamic Therapy Photosensitizers. Chemistry 2017; 23:9888-9896. [DOI: 10.1002/chem.201701392] [Citation(s) in RCA: 79] [Impact Index Per Article: 11.3] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/28/2017] [Indexed: 01/16/2023]
Affiliation(s)
- Jeannine Hess
- Department of Chemistry; University of Zurich; Winterthurerstrasse 190 8057 Zurich Switzerland
| | - Huaiyi Huang
- Department of Chemistry; University of Zurich; Winterthurerstrasse 190 8057 Zurich Switzerland
- School of Chemistry; Sun Yat-Sen University; Guangzhou 510275 P. R. China
| | - Adrian Kaiser
- Department of Chemistry; University of Zurich; Winterthurerstrasse 190 8057 Zurich Switzerland
| | - Vanessa Pierroz
- Department of Chemistry; University of Zurich; Winterthurerstrasse 190 8057 Zurich Switzerland
| | - Olivier Blacque
- Department of Chemistry; University of Zurich; Winterthurerstrasse 190 8057 Zurich Switzerland
| | - Hui Chao
- School of Chemistry; Sun Yat-Sen University; Guangzhou 510275 P. R. China
| | - Gilles Gasser
- Chimie ParisTech; PSL Research University; Laboratory for Inorganic Chemical Biology; 75005 Paris France
| |
Collapse
|
14
|
Praziquantel for Schistosomiasis: Single-Drug Metabolism Revisited, Mode of Action, and Resistance. Antimicrob Agents Chemother 2017; 61:AAC.02582-16. [PMID: 28264841 DOI: 10.1128/aac.02582-16] [Citation(s) in RCA: 217] [Impact Index Per Article: 31.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/07/2023] Open
Abstract
Schistosomiasis, a major neglected tropical disease, affects more than 250 million people worldwide. Treatment of schistosomiasis has relied on the anthelmintic drug praziquantel (PZQ) for more than a generation. PZQ is the drug of choice for the treatment of schistosomiasis; it is effective against all major forms of schistosomiasis, although it is less active against juvenile than mature parasites. A pyrazino-isoquinoline derivative, PZQ is not considered to be toxic and generally causes few or transient, mild side effects. Increasingly, mass drug administration targeting populations in sub-Saharan Africa where schistosomiasis is endemic has led to the appearance of reduced efficacy of PZQ, which portends the selection of drug-resistant forms of these pathogens. The synthesis of improved derivatives of PZQ is attracting attention, e.g., in the (i) synthesis of drug analogues, (ii) rational design of pharmacophores, and (iii) discovery of new compounds from large-scale screening programs. This article reviews reports from the 1970s to the present on the metabolism and mechanism of action of PZQ and its derivatives against schistosomes.
Collapse
|
15
|
Barbosa MIF, Correa RS, Bastos TM, Pozzi LV, Moreira DRM, Ellena J, Doriguetto AC, Silveira RG, Oliveira CR, Kuznetsov AE, Malta VS, Soares MBP, Batista AA. Structural isomerism of Ru(ii)-carbonyl complexes: synthesis, characterization and their antitrypanosomal activities. NEW J CHEM 2017. [DOI: 10.1039/c7nj00125h] [Citation(s) in RCA: 10] [Impact Index Per Article: 1.4] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/03/2023]
Abstract
New complexes with the formula [RuCl(CO)(dppb)(N–N)]PF6 were prepared by varying the CO position as well as the diimine ligand.
Collapse
|
16
|
Hess J, Patra M, Rangasamy L, Konatschnig S, Blacque O, Jabbar A, Mac P, Jorgensen EM, Gasser RB, Gasser G. Organometallic Derivatization of the Nematocidal Drug Monepantel Leads to Promising Antiparasitic Drug Candidates. Chemistry 2016; 22:16602-16612. [DOI: 10.1002/chem.201602851] [Citation(s) in RCA: 18] [Impact Index Per Article: 2.3] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/15/2016] [Indexed: 12/20/2022]
Affiliation(s)
- Jeannine Hess
- Department of Chemistry University of Zurich Winterthurerstrasse 190 8057 Zurich Switzerland
| | - Malay Patra
- Department of Chemistry University of Zurich Winterthurerstrasse 190 8057 Zurich Switzerland
| | - Loganathan Rangasamy
- Department of Chemistry University of Zurich Winterthurerstrasse 190 8057 Zurich Switzerland
| | - Sandro Konatschnig
- Department of Chemistry University of Zurich Winterthurerstrasse 190 8057 Zurich Switzerland
| | - Olivier Blacque
- Department of Chemistry University of Zurich Winterthurerstrasse 190 8057 Zurich Switzerland
| | - Abdul Jabbar
- Faculty of Veterinary and Agricultural Sciences The University of Melbourne Parkville, Victoria 3010 Australia
| | - Patrick Mac
- Howard Hughes Medical Institute Department of Biology University of Utah Salt Lake City UT 84112-0840 USA
| | - Erik M. Jorgensen
- Howard Hughes Medical Institute Department of Biology University of Utah Salt Lake City UT 84112-0840 USA
| | - Robin B. Gasser
- Faculty of Veterinary and Agricultural Sciences The University of Melbourne Parkville, Victoria 3010 Australia
| | - Gilles Gasser
- Department of Chemistry University of Zurich Winterthurerstrasse 190 8057 Zurich Switzerland
| |
Collapse
|
17
|
Hess J, Patra M, Pierroz V, Spingler B, Jabbar A, Ferrari S, Gasser RB, Gasser G. Synthesis, Characterization, and Biological Activity of Ferrocenyl Analogues of the Anthelmintic Drug Monepantel. Organometallics 2016. [DOI: 10.1021/acs.organomet.6b00577] [Citation(s) in RCA: 20] [Impact Index Per Article: 2.5] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022]
Affiliation(s)
- Jeannine Hess
- Department
of Chemistry, University of Zurich, Winterthurerstrasse 190, CH-8057 Zurich, Switzerland
| | - Malay Patra
- Department
of Chemistry, University of Zurich, Winterthurerstrasse 190, CH-8057 Zurich, Switzerland
| | - Vanessa Pierroz
- Department
of Chemistry, University of Zurich, Winterthurerstrasse 190, CH-8057 Zurich, Switzerland
- Institute
of Molecular Cancer Research, University of Zurich, Winterthurerstrasse
190, CH-8057 Zurich, Switzerland
| | - Bernhard Spingler
- Department
of Chemistry, University of Zurich, Winterthurerstrasse 190, CH-8057 Zurich, Switzerland
| | - Abdul Jabbar
- Faculty
of Veterinary and Agricultural Sciences, The University of Melbourne, Parkville, Victoria 3010, Australia
| | - Stefano Ferrari
- Institute
of Molecular Cancer Research, University of Zurich, Winterthurerstrasse
190, CH-8057 Zurich, Switzerland
| | - Robin B. Gasser
- Faculty
of Veterinary and Agricultural Sciences, The University of Melbourne, Parkville, Victoria 3010, Australia
| | - Gilles Gasser
- Department
of Chemistry, University of Zurich, Winterthurerstrasse 190, CH-8057 Zurich, Switzerland
| |
Collapse
|
18
|
Clède S, Cowan N, Lambert F, Bertrand HC, Rubbiani R, Patra M, Hess J, Sandt C, Trcera N, Gasser G, Keiser J, Policar C. Bimodal X-ray and Infrared Imaging of an Organometallic Derivative of Praziquantel inSchistosoma mansoni. Chembiochem 2016; 17:1004-7. [DOI: 10.1002/cbic.201500688] [Citation(s) in RCA: 15] [Impact Index Per Article: 1.9] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/23/2015] [Indexed: 12/22/2022]
Affiliation(s)
- Sylvain Clède
- École Normale Supérieure; PSL Research University; Département de Chimie; 24 rue Lhomond 75005 Paris France
- Sorbonne Universités; UPMC Univ Paris 06; LBM; 4 place Jussieu 75005 Paris France
- Centre National de la Recherche Scientifique (CNRS); UMR 7203 LBM; 75005 Paris France
| | - Noemi Cowan
- Department of Medical Parasitology and Infection Biology; Swiss Tropical and Public Health Institute Basel, Switzerland; University of Basel; P. O. Box 4003 Basel Switzerland
| | - François Lambert
- École Normale Supérieure; PSL Research University; Département de Chimie; 24 rue Lhomond 75005 Paris France
- Sorbonne Universités; UPMC Univ Paris 06; LBM; 4 place Jussieu 75005 Paris France
- Centre National de la Recherche Scientifique (CNRS); UMR 7203 LBM; 75005 Paris France
| | - Hélène C. Bertrand
- École Normale Supérieure; PSL Research University; Département de Chimie; 24 rue Lhomond 75005 Paris France
- Sorbonne Universités; UPMC Univ Paris 06; LBM; 4 place Jussieu 75005 Paris France
- Centre National de la Recherche Scientifique (CNRS); UMR 7203 LBM; 75005 Paris France
| | - Riccardo Rubbiani
- Department of Chemistry; University of Zürich; Winterthurerstrasse 190 8057 Zürich Switzerland
| | - Malay Patra
- Department of Chemistry; University of Zürich; Winterthurerstrasse 190 8057 Zürich Switzerland
| | - Jeannine Hess
- Department of Chemistry; University of Zürich; Winterthurerstrasse 190 8057 Zürich Switzerland
| | - Christophe Sandt
- Synchrotron SOLEIL; L'Orme des Merisiers, Saint Aubin B. P. 48 91192 Gif-sur-Yvette France
| | - Nicolas Trcera
- Synchrotron SOLEIL; L'Orme des Merisiers, Saint Aubin B. P. 48 91192 Gif-sur-Yvette France
| | - Gilles Gasser
- Department of Chemistry; University of Zürich; Winterthurerstrasse 190 8057 Zürich Switzerland
| | - Jennifer Keiser
- Department of Medical Parasitology and Infection Biology; Swiss Tropical and Public Health Institute Basel, Switzerland; University of Basel; P. O. Box 4003 Basel Switzerland
| | - Clotilde Policar
- École Normale Supérieure; PSL Research University; Département de Chimie; 24 rue Lhomond 75005 Paris France
- Sorbonne Universités; UPMC Univ Paris 06; LBM; 4 place Jussieu 75005 Paris France
- Centre National de la Recherche Scientifique (CNRS); UMR 7203 LBM; 75005 Paris France
| |
Collapse
|
19
|
Song LJ, Luo H, Fan WH, Wang GP, Yin XR, Shen S, Wang J, Jin Y, Zhang W, Gao H, Liu Q, Wang WL, Feng B, Yu CX. Oxadiazole-2-oxides may have other functional targets, in addition to SjTGR, through which they cause mortality in Schistosoma japonicum. Parasit Vectors 2016; 9:26. [PMID: 26791563 PMCID: PMC4721062 DOI: 10.1186/s13071-016-1301-3] [Citation(s) in RCA: 12] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/07/2015] [Accepted: 01/08/2016] [Indexed: 12/29/2022] Open
Abstract
BACKGROUND Schistosomiasis is one of the world's major public health problems. Besides praziquantel (PZQ), there is currently no other effective treatment against schistosomiasis. The development of new antischistosomal agents to curb the emergence of PZQ resistance should be a high priority. Oxadiazole-2-oxides have been identified as potential antischistosomal reagents, with thioredoxin glutathione reductase (TGR) being one of their molecular targets. METHODS To develop novel treatment reagents against Schistosoma japonicum, 30 novel oxadiazole-2-oxides were synthesised and their antischistosomal activities on juvenile and adult S. japonicum were evaluated in vitro and in vivo. Their inhibitory activities against S. japonicum thioredoxin glutathione reductase (SjTGR) were also analysed. RESULTS Most of the oxadiazole-2-oxides showed good juvenile and adult S. japonica killing activities in vitro. However, the antischistosomal effects of these compounds were not positively correlated with either their inhibition of SjTGR, or with nitric oxide (NO) release. Compounds 4a, 4b, 7c, 13, 16 and 20 resulted in 87.7%, 83.1%, 87.1%, 84.6%, 90.8% and 69.5%, respectively, mortality in the adult worms, when used to treat infected mice at schistosomula stage. These mortality rates were similar to or higher than that of artemisinin. Furthermore, compounds 4a and 16 resulted in 66.7% and 69.4% reductions in the worm burdens, respectively, when infected mice were treated at the adult worm stage. These treatment effects were similar to PZQ. No differences in activity of the oxadiazole-2-oxides against female and male adult worms were observed. The toxicity of the oxadiazole-2-oxides on mammalian cells appeared to be similar to, or less than, that of PZQ. CONCLUSIONS The antischistosomal activity of the oxadiazole-2-oxides does not depend on NO production or the inhibition of SjTGR activity. There may be other functional targets of the oxadiazole-2-oxides in S. japonicum. Several of the novel oxadiazole-2-oxides synthesised in this study could be used to develop novel antischistosomal drugs and explore potential molecular targets.
Collapse
Affiliation(s)
- Li-Jun Song
- Key Laboratory on Technology for Disease Prevention and Control, Ministry of Health, Jiangsu Provincial Key laboratory of Parasite Molecular Biology, Jiangsu Institute of Parasitic Diseases, Wuxi, Jiangsu, 214064, China.
- Public Health Research Center, Jiangnan University, Wuxi, 214122, China.
| | - Huan Luo
- School of Pharmaceutical Science, Jiangnan University, Wuxi, 214122, China.
| | - Wen-Hua Fan
- School of Pharmaceutical Science, Jiangnan University, Wuxi, 214122, China.
| | - Gu-Ping Wang
- School of Pharmaceutical Science, Jiangnan University, Wuxi, 214122, China.
| | - Xu-Ren Yin
- Key Laboratory on Technology for Disease Prevention and Control, Ministry of Health, Jiangsu Provincial Key laboratory of Parasite Molecular Biology, Jiangsu Institute of Parasitic Diseases, Wuxi, Jiangsu, 214064, China.
- Public Health Research Center, Jiangnan University, Wuxi, 214122, China.
| | - Shuang Shen
- Key Laboratory on Technology for Disease Prevention and Control, Ministry of Health, Jiangsu Provincial Key laboratory of Parasite Molecular Biology, Jiangsu Institute of Parasitic Diseases, Wuxi, Jiangsu, 214064, China.
- Public Health Research Center, Jiangnan University, Wuxi, 214122, China.
| | - Jie Wang
- Key Laboratory on Technology for Disease Prevention and Control, Ministry of Health, Jiangsu Provincial Key laboratory of Parasite Molecular Biology, Jiangsu Institute of Parasitic Diseases, Wuxi, Jiangsu, 214064, China.
- Public Health Research Center, Jiangnan University, Wuxi, 214122, China.
| | - Yi Jin
- Key Laboratory on Technology for Disease Prevention and Control, Ministry of Health, Jiangsu Provincial Key laboratory of Parasite Molecular Biology, Jiangsu Institute of Parasitic Diseases, Wuxi, Jiangsu, 214064, China.
- Public Health Research Center, Jiangnan University, Wuxi, 214122, China.
| | - Wei Zhang
- Key Laboratory on Technology for Disease Prevention and Control, Ministry of Health, Jiangsu Provincial Key laboratory of Parasite Molecular Biology, Jiangsu Institute of Parasitic Diseases, Wuxi, Jiangsu, 214064, China.
- Public Health Research Center, Jiangnan University, Wuxi, 214122, China.
| | - Hong Gao
- Key Laboratory on Technology for Disease Prevention and Control, Ministry of Health, Jiangsu Provincial Key laboratory of Parasite Molecular Biology, Jiangsu Institute of Parasitic Diseases, Wuxi, Jiangsu, 214064, China.
- Public Health Research Center, Jiangnan University, Wuxi, 214122, China.
| | - Qian Liu
- Key Laboratory on Technology for Disease Prevention and Control, Ministry of Health, Jiangsu Provincial Key laboratory of Parasite Molecular Biology, Jiangsu Institute of Parasitic Diseases, Wuxi, Jiangsu, 214064, China.
- Public Health Research Center, Jiangnan University, Wuxi, 214122, China.
| | - Wen-Long Wang
- School of Pharmaceutical Science, Jiangnan University, Wuxi, 214122, China.
| | - Bainian Feng
- School of Pharmaceutical Science, Jiangnan University, Wuxi, 214122, China.
| | - Chuan-Xin Yu
- Key Laboratory on Technology for Disease Prevention and Control, Ministry of Health, Jiangsu Provincial Key laboratory of Parasite Molecular Biology, Jiangsu Institute of Parasitic Diseases, Wuxi, Jiangsu, 214064, China.
- Public Health Research Center, Jiangnan University, Wuxi, 214122, China.
- Medical College, Jiangnan University, Wuxi, 214122, China.
| |
Collapse
|
20
|
Hess J, Patra M, Jabbar A, Pierroz V, Konatschnig S, Spingler B, Ferrari S, Gasser RB, Gasser G. Assessment of the nematocidal activity of metallocenyl analogues of monepantel. Dalton Trans 2016; 45:17662-17671. [DOI: 10.1039/c6dt03376h] [Citation(s) in RCA: 9] [Impact Index Per Article: 1.1] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/31/2022]
Abstract
Ferrocenyl and ruthenocenyl analogues of the nematocidal drug monepantel show organometallic-dependent activity against Haemonchus contortus and Trichostrongylus colubriformis.
Collapse
Affiliation(s)
- Jeannine Hess
- Department of Chemistry
- University of Zurich
- CH-8057 Zurich
- Switzerland
| | - Malay Patra
- Department of Chemistry
- University of Zurich
- CH-8057 Zurich
- Switzerland
| | - Abdul Jabbar
- Faculty of Veterinary and Agricultural Sciences
- The University of Melbourne
- Parkville
- Australia
| | - Vanessa Pierroz
- Department of Chemistry
- University of Zurich
- CH-8057 Zurich
- Switzerland
- Institute of Molecular Cancer Research
| | | | - Bernhard Spingler
- Department of Chemistry
- University of Zurich
- CH-8057 Zurich
- Switzerland
| | - Stefano Ferrari
- Institute of Molecular Cancer Research
- University of Zurich
- CH-8057 Zurich
- Switzerland
| | - Robin B. Gasser
- Faculty of Veterinary and Agricultural Sciences
- The University of Melbourne
- Parkville
- Australia
| | - Gilles Gasser
- Department of Chemistry
- University of Zurich
- CH-8057 Zurich
- Switzerland
| |
Collapse
|
21
|
Simpson PV, Nagel C, Bruhn H, Schatzschneider U. Antibacterial and Antiparasitic Activity of Manganese(I) Tricarbonyl Complexes with Ketoconazole, Miconazole, and Clotrimazole Ligands. Organometallics 2015. [DOI: 10.1021/acs.organomet.5b00458] [Citation(s) in RCA: 58] [Impact Index Per Article: 6.4] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/16/2022]
Affiliation(s)
- Peter V. Simpson
- Institut
für Anorganische Chemie, Julius-Maximilians-Universität Würzburg, Am Hubland, D-97074 Würzburg, Germany
| | - Christoph Nagel
- Institut
für Anorganische Chemie, Julius-Maximilians-Universität Würzburg, Am Hubland, D-97074 Würzburg, Germany
| | - Heike Bruhn
- Institut
für Molekulare Infektionsbiologie, Julius-Maximilians-Universität Würzburg, Josef-Schneider-Strasse 2/D15, D-97080 Würzburg, Germany
| | - Ulrich Schatzschneider
- Institut
für Anorganische Chemie, Julius-Maximilians-Universität Würzburg, Am Hubland, D-97074 Würzburg, Germany
| |
Collapse
|
22
|
Abstract
In the recent years, there has been a growing interest in the use of novel approaches for the treatment of parasitic diseases such as schistosomiasis. Among the different approaches used, organometallic compounds were found to offer unique opportunities in the design of antiparasitic drug candidates. A ferrocenyl derivative, namely ferroquine, has even entered clinical trials as a novel antimalarial. In this short review, we report on the studies describing the use of organometallic compounds against schistosomiasis.
Collapse
|
23
|
Brown RW, Hyland CJT. Medicinal organometallic chemistry – an emerging strategy for the treatment of neglected tropical diseases. MEDCHEMCOMM 2015. [DOI: 10.1039/c5md00174a] [Citation(s) in RCA: 33] [Impact Index Per Article: 3.7] [Reference Citation Analysis] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 01/09/2023]
Abstract
This review summarises recent developments in the search for novel organometallic drug compounds for the treatment of neglected tropical diseases.
Collapse
|
24
|
Leonidova A, Pierroz V, Adams LA, Barlow N, Ferrari S, Graham B, Gasser G. Enhanced Cytotoxicity through Conjugation of a "Clickable" Luminescent Re(I) Complex to a Cell-Penetrating Lipopeptide. ACS Med Chem Lett 2014; 5:809-14. [PMID: 25050170 DOI: 10.1021/ml500158w] [Citation(s) in RCA: 59] [Impact Index Per Article: 5.9] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/23/2014] [Accepted: 05/15/2014] [Indexed: 01/10/2023] Open
Abstract
Re(I) tricarbonyl polypyridine-based complexes are particularly attractive metal complexes in the field of inorganic chemical biology due to their luminescent properties, ease of conjugation to targeting biomolecules, and the possibility to prepare their "hot" (99m)Tc analogues for radioimaging. In this study, we prepared and characterized a novel, "clickable" complex, [Re(2,2'-bipyridine)(3-ethynylpyridine)(CO)3](BF4) ([Re(CO) 3 (bipy)(py-alkyne)](BF 4 )), exhibiting the characteristic luminescent properties and moderate cytotoxicity of this general class of compound. Using Cu(I)-catalyzed "click" chemistry, the complex was efficiently attached to a lipidated peptide known to increase cell permeability, namely, the myristoylated HIV-1 Tat peptide (myr-Tat), to give Re-myr-Tat. Fluorescence microscopy localization in human cervical cancer cells (HeLa) confirmed enhanced cellular uptake of Re-myr-Tat compared with [Re(CO) 3 (bipy)(py-alkyne)](BF 4 ), and cytotoxicity studies showed that this resulted in an increase in potency to a level comparable with cisplatin (13.0 ± 2.0 μM).
Collapse
Affiliation(s)
- Anna Leonidova
- Department
of Chemistry, University of Zurich, Winterthurerstrasse 190, CH-8057 Zurich, Switzerland
| | - Vanessa Pierroz
- Department
of Chemistry, University of Zurich, Winterthurerstrasse 190, CH-8057 Zurich, Switzerland
- Institute of Molecular Cancer Research, Winterthurerstrasse 190, CH-8057 Zurich, Switzerland
| | - Luke A. Adams
- Monash
Institute of Pharmaceutical Sciences, Monash University, 381 Royal
Parade, Parkville, Victoria 3052, Australia
| | - Nicholas Barlow
- Monash
Institute of Pharmaceutical Sciences, Monash University, 381 Royal
Parade, Parkville, Victoria 3052, Australia
| | - Stefano Ferrari
- Institute of Molecular Cancer Research, Winterthurerstrasse 190, CH-8057 Zurich, Switzerland
| | - Bim Graham
- Monash
Institute of Pharmaceutical Sciences, Monash University, 381 Royal
Parade, Parkville, Victoria 3052, Australia
| | - Gilles Gasser
- Department
of Chemistry, University of Zurich, Winterthurerstrasse 190, CH-8057 Zurich, Switzerland
| |
Collapse
|
25
|
Kitanovic I, Can S, Alborzinia H, Kitanovic A, Pierroz V, Leonidova A, Pinto A, Spingler B, Ferrari S, Molteni R, Steffen A, Metzler-Nolte N, Wölfl S, Gasser G. A deadly organometallic luminescent probe: anticancer activity of a ReI bisquinoline complex. Chemistry 2014; 20:2496-507. [PMID: 24464824 DOI: 10.1002/chem.201304012] [Citation(s) in RCA: 66] [Impact Index Per Article: 6.6] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/14/2013] [Indexed: 12/25/2022]
Abstract
The photophysical properties of [Re(CO)3 (L-N3)]Br (L-N3 =2-azido-N,N-bis[(quinolin-2-yl)methyl]ethanamine), which could not be localized in cancer cells by fluorescence microscopy, have been revisited in order to evaluate its use as a luminescent probe in a biological environment. The Re(I) complex displays concentration-dependent residual fluorescence besides the expected phosphorescence, and the nature of the emitting excited states have been evaluated by DFT and time-dependent (TD) DFT methods. The results show that fluorescence occurs from a (1) LC/MLCT state, whereas phosphorescence mainly stems from a (3) LC state, in contrast to previous assignments. We found that our luminescent probe, [Re(CO)3 (L-N3)]Br, exhibits an interesting cytotoxic activity in the low micromolar range in various cancer cell lines. Several biochemical assays were performed to unveil the cytotoxic mechanism of the organometallic Re(I) bisquinoline complex. [Re(CO)3 (L-N3)]Br was found to be stable in human plasma indicating that [Re(CO)3 (L-N3)]Br itself and not a decomposition product is responsible for the observed cytotoxicity. Addition of [Re(CO)3 (L-N3)]Br to MCF-7 breast cancer cells grown on a biosensor chip micro-bioreactor immediately led to reduced cellular respiration and increased glycolysis, indicating a large shift in cellular metabolism and inhibition of mitochondrial activity. Further analysis of respiration of isolated mitochondria clearly showed that mitochondrial respiratory activity was a direct target of [Re(CO)3 (L-N3)]Br and involved two modes of action, namely increased respiration at lower concentrations, potentially through increased proton transport through the inner mitochondrial membrane, and efficient blocking of respiration at higher concentrations. Thus, we believe that the direct targeting of mitochondria in cells by [Re(CO)3 (L-N3)]Br is responsible for the anticancer activity.
Collapse
Affiliation(s)
- Igor Kitanovic
- Department of Bioanalytics and Molecular Biology, Institute for Pharmacy and Molecular Biology, University of Heidelberg im Neuenheimer Feld 364, 69120 Heidelberg (Germany), Tel: (+49) 622-1544-878 http://www.uni-heidelberg.de/fakultaeten/biowissenschaften/ipmb/biologie/woelfl/index.html
| | | | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
26
|
Cedillo-Cruz A, Aguilar MI, Jung-Cook H. (S)-(+)-cis-4'-Benzyl-oxypraziquantel. Acta Crystallogr Sect E Struct Rep Online 2013; 69:o1835-6. [PMID: 24454256 PMCID: PMC3885080 DOI: 10.1107/s1600536813031735] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/31/2013] [Accepted: 11/20/2013] [Indexed: 05/28/2023]
Abstract
The asymmetric unit of the title compound, C26H30N2O3 {systematic name (S)-(+)-2-[cis-4-(benzyloxy)cyclohexanecarbonyl]-1,2,3,6,7,11b-hexahydro-4H-pyrazino[2,1-a]isoquinolin-4-one}, consists of two independent molecules in which the O= Camide group is syn to the N—C(C=Olactam) moiety, making dihedral angles of 2.0 (8) and 3.7 (8)°. The conformation of the 1,4-disubstituted cyclohexane ring is cis in each independent molecule, with the carbonyl group occupying an equatorial position and the benzyloxy group an axial position. In one molecule, two C and one O atom of the benzyloxy group are disordered over two sets of sites, with a refined occupancy ratio of 0.772 (8):0.228 (8). In the crystal, molecules are linked by C—H⋯O interactions, forming ribbons parallel to the b-axis direction.
Collapse
Affiliation(s)
- Alberto Cedillo-Cruz
- Departamento de Farmacia, Facultad de Química, Universidad Nacional Autónoma de México, 04510 México, DF, Mexico
| | - María Isabel Aguilar
- Departamento de Farmacia, Facultad de Química, Universidad Nacional Autónoma de México, 04510 México, DF, Mexico
| | - Helgi Jung-Cook
- Departamento de Farmacia, Facultad de Química, Universidad Nacional Autónoma de México, 04510 México, DF, Mexico
| |
Collapse
|
27
|
Patra M, Ingram K, Leonidova A, Pierroz V, Ferrari S, Robertson MN, Todd MH, Keiser J, Gasser G. In Vitro Metabolic Profile and in Vivo Antischistosomal Activity Studies of (η6-Praziquantel)Cr(CO)3 Derivatives. J Med Chem 2013; 56:9192-8. [DOI: 10.1021/jm401287m] [Citation(s) in RCA: 38] [Impact Index Per Article: 3.5] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/23/2022]
Affiliation(s)
| | - Katrin Ingram
- Department
of Medical Parasitology and Infection Biology, Swiss Tropical and
Public Health Institute, CH-4051 Basel, Switzerland and University of Basel, P.O. Box, CH-4003 Basel, Switzerland
| | | | | | | | - Murray N. Robertson
- School
of Chemistry, The University of Sydney, New South Wales 2006, Australia
| | - Matthew H. Todd
- School
of Chemistry, The University of Sydney, New South Wales 2006, Australia
| | - Jennifer Keiser
- Department
of Medical Parasitology and Infection Biology, Swiss Tropical and
Public Health Institute, CH-4051 Basel, Switzerland and University of Basel, P.O. Box, CH-4003 Basel, Switzerland
| | | |
Collapse
|
28
|
Synthesis and SAR studies of praziquantel derivatives with activity against Schistosoma japonicum. Molecules 2013; 18:9163-78. [PMID: 23912271 PMCID: PMC6269691 DOI: 10.3390/molecules18089163] [Citation(s) in RCA: 12] [Impact Index Per Article: 1.1] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/25/2013] [Revised: 07/24/2013] [Accepted: 07/25/2013] [Indexed: 11/17/2022] Open
Abstract
The synthesis and structure-activity relationship (SAR) studies of praziquantel derivatives with activity against adult Schistosoma japonicum are described. Several of them showed better worm killing activity than praziquantel and could serve as leads for further optimization.
Collapse
|